Waltrop

NextPharma Waltrop has extensive experience and a proven track record in pharmaceutical development, commercial manufacturing, commercial packaging of hormonal tablets (e.g. oral contraceptives) as well as hormone containing gels and creams which are produced in dedicated areas.  

In addition, the team has extensive know-how in the semi-solid formulation, development and commercial processing of semi-solid products, both hormonal or non-hormonal, with a positive track record of product launches.

The following services are offered

Pharmaceutical Development

  • Pharmaceutical formulation development
  • Scale-up (pilot-scale, production-scale)
  • Validation
  • Manufacturing of stability batches
  • Galenic optimisation of existing formulae
  • Registration services

Analytics

  • Analytical development
  • Validation
  • Stability testing / storage
  • Quality control
  • Market release

Commercial Manufacturing and Packaging

Hormonal solids 1,800m tablets
Hormonal semi-solids 200 tonnes
Hormonal solids blistering 55m blisters
Standard liquids 1,8m litres
Filling of oral and topical liquids 25m units
Standard semi-solids 200 tonnes
Standard solids blistering 25m blisters
Manufacturing 4,300 m²
Regulatory status Anvisa (Brazil), EMA, FDA (USA)

Site contact information

Address

NextPharma
Im Wirrigen 25
D-45731 Waltrop
Germany

Fax

+49-2309-9375-313